High-intensity, low-frequency rTMS to the right prefrontal cortex for heart-rate control in women with recurrent pregnancy loss and anxiety
Official title: High-intensity, Low-frequency Periodic rTMS Over the Right Dorsolateral Prefrontal Cortex for Acute Cardiac Autonomic Regulation in Women With Recurrent Pregnancy Loss and Generalized Anxiety Disorder: a Randomized, Sham-controlled Mechanistic Trial (NEURO-CARD-rTMS-2)
Run by Shenyang Medical College · NCT07233278 · Data updated 2026-11-12
This test will see if a single session of high-intensity, low-frequency rTMS to the right dorsolateral prefrontal cortex can change heart rate and heart-rate variability in women with recurrent pregnancy loss who have anxiety.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 45 Years |
| Sex | Women only |
| Enrollment | 48 (estimated) |
| Sponsor | Shenyang Medical College Academic / other |
| Locations | 3 sites (Shenyang, Liaoning and 2 other locations) |
| Status | Recruiting |
| Started | November 19, 2025 |
| Main results expected | June 22, 2026 |
| Study ends | January 12, 2027 |
| Registry record updated | November 3, 2026 |
| Trial ID | NCT07233278 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Women aged 18–45, right-handed, not currently pregnant, with at least two prior pregnancy losses before viability and a DSM-5 anxiety disorder, who have no contraindications to TMS, would be ideal candidates.
✕Probably not a fit
People who are male, currently pregnant, have major organic cardiac or neurologic conditions, active substance use or other excluded psychiatric disorders, or contraindications to TMS are unlikely to benefit from this protocol.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a randomized, sham-controlled, proof-of-concept trial that delivers a single session of rhythmic low-frequency rTMS (120% resting motor threshold, 1 Hz) to the right dorsolateral prefrontal cortex with 20 consecutive 60-second stimulation windows. Participants are women aged 18–45 with a history of two or more pregnancy losses and a DSM-5 anxiety disorder, and they are compared to a matched sham stimulation group. The primary physiological outcomes are within-session heart rate changes and heart-rate-variability spectral power at the target rhythm (0.0167 Hz). The protocol builds on a prior dose-finding study and focuses on short-term modulation of cardiac autonomic markers rather than reproductive outcomes.
Why it matters
Potential benefit: If successful, the intervention could offer a noninvasive way to lower sympathetic drive and improve heart-rate variability in women with recurrent pregnancy loss and anxiety, potentially reducing stress-related cardiovascular risk.
How similar studies have gone: Early dose-finding work and small rTMS studies have shown that prefrontal stimulation can alter autonomic metrics, but this specific high-intensity, low-frequency rhythmic protocol for RPL with anxiety is a novel, proof-of-concept application.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * (i) Female, aged 18-45 years, and right-handed; * (ii) Diagnosed with recurrent pregnancy loss (RPL), defined as two or more consecutive spontaneous miscarriages occurring before 28 weeks of gestation; * (iii) Not currently pregnant or in a state of missed miscarriage; * (iv) Meeting the DSM-5 diagnostic criteria for GAD, with a HAMA score of at least 16, a CGI-S score of at least 4, and a HAMD-17 score of no more than 17. Exclusion Criteria: * (i) Contraindications to transcranial magnetic stimulation (TMS), such as metallic implants or a history of epilepsy; * (ii) Unstable blood pressure (systolic \>180 mmHg or \<90 mmHg); * (iii) Coexisting major organic disorders, including hyperthyroidism, atrial fibrillation, valvular heart disease, sinus bradycardia, neurological diseases, cerebrovascular disease, or pulmonary disorders; * (iv) Significant suicide risk; * (v) Other current major psychiatric disorders, including substance use disorder, schizophrenia, delusional disorder, unspecified psychotic disorder, bipolar disorder, or delirium. To preserve diagnostic homogeneity of the study sample, participants whose current primary diagnosis is another anxiety-related disorder will also be excluded, including panic disorder, social anxiety disorder, separation anxiety disorder, specific phobia, obsessive-compulsive and related disorders, and trauma- and stressor-related disorders; Current use of psychotropic medication at screening, or continuous use within the 4 weeks before screening of antidepressants, anxiolytics, antipsychotics, mood stabilizers, or sedative-hypnotics, in order to minimize hemodynamic confounding.
Where it's running
-
The Second Affiliated Hospital of Shenyang Medical College
Shenyang, Liaoning, China Recruiting -
Central Hospital Affiliated to Shenyang Medical College
Shenyang, Liaoning, China Recruiting -
242 Hospital Affiliated to Shenyang Medical College
Shenyang, Liaoning, China Recruiting
Study contacts
- Principal investigator: Lin Tao, MM — Shenyang Medical College
- Study coordinator: Fei Meng, MD
- Email: mengfei665@sohu.com
- Phone: 86-024-85715635
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Single-session intervention to change ambiguity aversion
This trial tests whether one brief intervention can change how adults with intolerance of uncertainty and anxiety make ambiguous decisions and how their brains respond.
-
See if preoperative anxiety affects recovery after major digestive cancer surgery
This study tests whether anxiety before surgery is linked to more complications after major digestive cancer operations in French-speaking adults.
-
Mindful Smartphone Use: A Mindfulness-Based Program for Teens with Sleep and Mood Challenges
This study tests Mindwire, a mindfulness-based program, to see if it helps teens with problematic phone use who also have depression or anxiety.
-
Tele-based wellbeing centres for women's mental health in Bangladesh
A randomized trial tests whether tele-counselling for depression and anxiety in Bangladeshi women is as effective as in-person counselling.
-
Buzzy Bee for Pain and Anxiety Control During Pediatric Dental Local Anesthesia
This study tests whether the Buzzy Bee device, with cold and vibration, reduces pain and anxiety during a dental injection in kids aged 5-7 compared with standard distraction.
-
Reflexology and hand massage after cesarean section
This study tests whether reflexology hand massage or stroking hand massage can reduce anxiety and increase satisfaction, and how they affect heart/blood pressure after cesarean delivery.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.